Wow, if I am reading this correctly, this is a huge validation of Miya Precision given that the research team will be using Alcidion’s product in a sort of top-down approach “...to identify priority areas where clinical decision support tools will add value”.
Any other interpretations?
Wow, if I am reading this correctly, this is a huge validation...
Add ALC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(1.82%) |
Mkt cap ! $72.49M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.3¢ | $24.32K | 450.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10959 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 365137 | 2 |
View Market Depth
| Last trade - 15.56pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
-0.001 ( 1.82 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.5¢ | 5.4¢ | 126200 | ||
| Last updated 15.56pm 30/04/2024 ? | |||||
| ALC (ASX) Chart |